“…16,17 The 22-minute dynamic protocol called for the simultaneous injection of MAG 3 and furosemide (MAG 3 -F 0 ) after oral hydration and without bladder catheterization. [42][43][44] During the next 8 years this protocol not only provided a reliable way to evaluate patients for obstruction and renovascular hypertension (RVH), thus continuing the HIP-F 3 experience, [5][6][7][8][9][10][11][12][13][14][15][16][17][18]29,40,41 but also opened a new world that facilitates the study of focal or diffuse diseases of the renal parenchyma (based on cortical activity accumulation and discharge). These new applications helped in the diagnosis and follow-up of a variety of DPD as well as that of APN, revealing the "regional parenchymal dysfunction," characteristic of APN.…”